RxDoctor Payments Data

Craig Levitz, MD

Sports Medicine · Rockville Centre, NYNPI 1942209507

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $29,607 of the $40,358 with a category attached, or 73.4%. 18 manufacturers reported payments, led by Smith+Nephew at 40.9% of the total. Reporting peaked in 2021 at $19,791 and has fallen 98.4% since, to $311 in 2025.

$40,358in general payments, 2019–2025

Across 96 payments — averaging $420.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$17K
  • Depuy Synthes Products, Inc.$10K
  • Johnson & Johnson$6K
  • Arthrex$3K
  • Gotham Surgical Solutions & Devices, Inc.$2K
  • Stryker$1K
  • plus $2K from 12 others

What the payments were for

  • Consulting fees$29,60773%
  • Travel & lodging$4,98512%
  • Food & beverage$3,90910%
  • Education$1,8585%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$40,358 in reported general payments places this provider in the 85th percentile of 403 sports medicine providers in New York.

See all sports medicine providers in New York

Medicare billing

Part B allowed, 2024
$410,199
Medicare patients
329
Services billed
10,087

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam100$401
Celecoxib24$372
Methylprednisolone38$210

Paid to pharmacies, not to this prescriber.

Other sports medicine in Rockville Centre

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →